BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 27439424)

  • 1. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
    Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
    BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype and phenotype correlation in von Hippel-Lindau disease based on alteration of the HIF-α binding site in VHL protein.
    Liu SJ; Wang JY; Peng SH; Li T; Ning XH; Hong BA; Liu JY; Wu PJ; Zhou BW; Zhou JC; Qi NN; Peng X; Zhang JF; Ma KF; Cai L; Gong K
    Genet Med; 2018 Oct; 20(10):1266-1273. PubMed ID: 29595810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
    Wittström E; Nordling M; Andréasson S
    Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.
    Vikkath N; Valiyaveedan S; Nampoothiri S; Radhakrishnan N; Pillai GS; Nair V; Pooleri GK; Mathew G; Menon KN; Ariyannur PS; Pillai AB
    Fam Cancer; 2015 Dec; 14(4):585-94. PubMed ID: 25952756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
    Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
    J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel genetic characterisation and phenotype correlation in von Hippel-Lindau (VHL) disease based on the Elongin C binding site: a large retrospective study.
    Xie H; Ma K; Zhang J; Hong B; Zhou J; Li L; Zhang K; Gong K; Cai L
    J Med Genet; 2020 Nov; 57(11):744-751. PubMed ID: 32303605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease.
    Mathó C; Sansó G; Diez B; Barontini M; Pennisi PA
    Genet Test Mol Biomarkers; 2016 Dec; 20(12):771-776. PubMed ID: 27617348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
    Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
    Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutation of Glu70Lys is highly frequent in Korean patients with von Hippel-Lindau (VHL) disease.
    Hwang S; Ku CR; Lee JI; Hur KY; Lee MS; Lee CH; Koo KY; Lee JS; Rhee Y
    J Hum Genet; 2014 Sep; 59(9):488-93. PubMed ID: 25078357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation links to von Hippel-Lindau syndrome in a Chinese family with hemangioblastoma.
    Fu XM; Zhao SL; Gui JC; Jiang YQ; Shen MN; Su DL; Gu BJ; Wang XQ; Ren QJ; Yin XD; Huang WB; Chen XG
    Genet Mol Res; 2015 May; 14(2):4513-20. PubMed ID: 25966224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-phenotype correlation in ocular von Hippel-Lindau (VHL) disease: the effect of missense mutation position on ocular VHL phenotype.
    Mettu P; Agrón E; Samtani S; Chew EY; Wong WT
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4464-70. PubMed ID: 20375333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial and genetic researches on three Chinese families with von Hippel-Lindau disease.
    Mao XC; Su ZP; Yu WQ; Zheng WM; Zeng YJ
    Neurol Res; 2009 Sep; 31(7):743-7. PubMed ID: 19133167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
    Salama Y; Albanyan S; Szybowska M; Bullivant G; Gallinger B; Giles RH; Asa S; Badduke C; Chiorean A; Druker H; Ezzat S; Hannah-Shmouni F; Hernandez KG; Inglese C; Jani P; Kaur Y; Krema H; Krimus L; Laperriere N; Lichner Z; Mete O; Sit M; Zadeh G; Jewett MAS; Malkin D; Stockley T; Wasserman JD; Xu W; Schachter NF; Kim RH
    Clin Genet; 2019 Nov; 96(5):461-467. PubMed ID: 31368132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
    Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
    Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
    Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
    J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.
    Webster AR; Maher ER; Moore AT
    Arch Ophthalmol; 1999 Mar; 117(3):371-8. PubMed ID: 10088816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural bioinformatics mutation analysis reveals genotype-phenotype correlations in von Hippel-Lindau disease and suggests molecular mechanisms of tumorigenesis.
    Forman JR; Worth CL; Bickerton GR; Eisen TG; Blundell TL
    Proteins; 2009 Oct; 77(1):84-96. PubMed ID: 19408298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.
    Clifford SC; Cockman ME; Smallwood AC; Mole DR; Woodward ER; Maxwell PH; Ratcliffe PJ; Maher ER
    Hum Mol Genet; 2001 May; 10(10):1029-38. PubMed ID: 11331613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.
    Dollfus H; Massin P; Taupin P; Nemeth C; Amara S; Giraud S; Béroud C; Dureau P; Gaudric A; Landais P; Richard S
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3067-74. PubMed ID: 12202531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The von Hippel-Lindau (VHL) germline mutation V84L manifests as early-onset bilateral pheochromocytoma.
    Abbott MA; Nathanson KL; Nightingale S; Maher ER; Greenstein RM
    Am J Med Genet A; 2006 Apr; 140(7):685-90. PubMed ID: 16502427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.